SPP1 and inflammatory bowel disease: Experimental models of colitis further support the involvement of OPN in IBD pathogenesis, as OPN deficiency results in reduced inflammation, suggesting that targeting OPN could offer a potential strategy to modulate the inflammatory cascade and alleviate disease severity of IBD.